Sickle Cell
Sickle Cell
Advertisement
Cecilia BrownSickle Cell | January 12, 2024
Nurse-administered and self-administered screening techniques can show different results.
Read More
Cecilia BrownSickle Cell | January 12, 2024
People with SCD are at a “high risk of hospitalization and mortality from COVID-19."
Cecilia BrownSickle Cell | January 11, 2024
RBC survival data may “inform hemoglobin composition thresholds required to reverse the phenotype after gene therapy."
Cecilia BrownSickle Cell | January 11, 2024
Acute pain vaso-occlusive episodes are the top cause of emergency department visits among people with SCD.
Cecilia BrownSickle Cell | January 11, 2024
Researchers said involving patients "is essential to improve participation and meet the real needs of the patient ...
Alicia Michaelsen, BSN, RN, BMTCN®Best Practices | December 22, 2023
Learn what nurses can do to help caregivers feel empowered in their role throughout the process.
Cecilia BrownSickle Cell | December 8, 2023
FDA officials called exagamglogene autotemcel and lovotibeglogene autotemcel “milestone treatments” for SCD.
Cecilia BrownConferences | December 7, 2023
An ASH speaker shares his insights on what clinicians and researchers are doing to minimize GVHD risks.
Dustin SamplesSickle Cell | October 17, 2023
Glutamine is FDA approved for the treatment of acute symptoms of sickle cell disease. Why isn’t medication adherence ...
Dustin SamplesHematology & Blood Cancer | October 17, 2023
Interprofessional team-based care is the standard for patients undergoing HSCT. But who belongs on the team?
Leah LawrenceSickle Cell | October 17, 2023
Literature on patient/family-provider communication in SCD is scarce, but it can be a key driver of health care quality.
Ariel JonesConferences | October 17, 2023
Patients with hematologic malignancies who may require blood transfusions may not be able to enroll in hospice care.
Ariel JonesConferences | October 17, 2023
This clinical outcome translates to meaningful improvement in health-related quality of life, according to researchers.
Ariel JonesConferences | October 17, 2023
Researchers evaluated the effects of etavopivat in two-week multiple ascending dose cohorts and a 12-week open-label study.
Ariel JonesConferences | October 17, 2023
Researchers found no increased risk for acute deep vein thrombosis post-vaccination for approved COVID-19 vaccines.
Ariel JonesConferences | October 17, 2023
Lead author Jacqueline N. Poston, MD, shared the findings.
Ariel JonesConferences | October 17, 2023
The present analysis updates findings from the ongoing phase 1/2 HGB-206 study.
Ariel JonesConferences | October 17, 2023
Researchers described the outcomes for pregnant women with SCD, who are considered at high risk for complications.
Keightley AmenSickle Cell | October 17, 2023
Healthcare providers may struggle with the decision to recommend hematopoietic cell transplantation (HCT) for children with ...
Keightley AmenSickle Cell | October 17, 2023
According to recent report in PLoS One, Medicaid enrollees who have sickle cell disease (SCD) are a high-need, high-cost ...
Advertisement
Advertisement
Advertisement